Stock IdeasStrong Buy StocksStrong Buy Stocks from Top Wall Street AnalystsLatest stocks with a Strong Buy rating from the top performing 25% of analysts tracked by WallStreetZen
Stock IdeasStrong Buy Stocks
| Analyst / Firm | Company | Price | Rating | Price Target | Upside/Downside | Date |
|---|---|---|---|---|---|---|
Neurocrine Biosciences IncNBIX | $127.78 | Strong Buy | $177.00 | +38.52% | 17 hours ago | |
Analyst RankingTop 4% #208 out of 5216 analysts Average Return+14.61% Win Rate47%115 out of 245 Risk vs RewardPoor Good Analyst ColorJP Morgan's Anupam Rama raised their price target on Neurocrine Biosciences (NASDAQ: NBIX) by 0.6% from $176 to $177 on 2026/03/12. The analyst maintained their Strong Buy rating on the stock. Rama attributed their price target increase for Neurocrine Biosciences to higher Crenessity estimates following feedback from 25 endocrinologists. The analyst called the survey results "encouraging" because they suggest "strong uptake" of Crenessity over the next year across key settings and physician populations. | ||||||
Tesla IncTSLA | $800.00 | Strong Buy | $850.00 | +6.25% | 2 days ago | |
Upgrade to Premium to View MoreStrong buys: Upgrade to Premium to view the rest of today's Strong Buy stocks from Wall Street's top analysts Already have access to Premium? Sign In | ||||||
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.